Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment
Crossref DOI link: https://doi.org/10.1158/0008-5472.CAN-16-3119
Published Online: 2017-06-14
Published Print: 2017-06-15
Update policy: https://doi.org/10.1158/crossmark_policy
Wang, Lili
Shi, Changying
Wright, Forrest A.
Guo, Dandan
Wang, Xu
Wang, Dongliang
Wojcikiewicz, Richard J.H.
Luo, Juntao
Funding for this research was provided by:
NIH (NIBIB 1R21EB019607)
New York State Health Department Peter T. Rowley Breast Cancer (DOH01-Rowley-2015-00067)